Pharmanutra S.p.A. (FRA:761)

Pharmanutra Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 29, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	606	523	542	601	730	364
Market Cap Growth	20.59%	-3.62%	-9.76%	-17.67%	100.53%	60.68%
Enterprise Value	605	523	552	595	710	350
Last Close Price	62.80	52.91	54.16	59.69	70.12	-
PE Ratio	34.73	31.47	42.26	39.94	53.01	25.87
PS Ratio	4.77	4.50	5.39	7.24	10.71	6.41
PB Ratio	9.17	8.40	9.97	11.80	16.19	9.65
P/TBV Ratio	14.54	12.79	16.38	19.87	18.30	11.18
P/FCF Ratio	58.13	32.16	-	-	47.32	35.98
P/OCF Ratio	41.94	25.50	44.85	34.41	35.76	30.85
EV/Sales Ratio	4.76	4.50	5.49	7.16	10.41	6.17
EV/EBITDA Ratio	19.11	17.29	21.72	24.56	36.76	23.19
EV/EBIT Ratio	21.47	19.11	24.00	25.78	38.78	24.71
EV/FCF Ratio	58.04	32.17	-	-	46.00	34.61
Debt / Equity Ratio	0.32	0.39	0.52	0.35	0.14	0.04
Debt / EBITDA Ratio	0.66	0.79	1.10	0.73	0.33	0.11
Debt / FCF Ratio	2.01	1.49	-	-	0.41	0.16
Asset Turnover	1.08	1.01	0.95	0.97	1.11	1.13
Inventory Turnover	6.81	7.53	7.76	10.13	15.13	16.15
Quick Ratio	1.60	1.95	1.70	1.96	3.08	3.39
Current Ratio	2.19	2.38	2.12	2.28	3.32	3.63
Return on Equity (ROE)	27.73%	28.39%	24.36%	31.34%	33.26%	42.73%
Return on Assets (ROA)	14.96%	14.88%	13.54%	16.82%	18.58%	17.61%
Return on Invested Capital (ROIC)	25.90%	29.08%	25.63%	50.00%	74.25%	82.60%
Return on Capital Employed (ROCE)	31.80%	30.40%	27.20%	31.00%	33.50%	34.90%
Earnings Yield	2.88%	3.18%	2.37%	2.50%	1.89%	3.87%
FCF Yield	1.72%	3.11%	-0.21%	-1.45%	2.11%	2.78%
Dividend Yield	1.53%	1.89%	1.57%	1.34%	1.01%	-
Payout Ratio	54.97%	49.20%	60.11%	45.53%	47.10%	31.64%
Buyback Yield / Dilution	0.58%	0.61%	0.05%	0.09%	-	-
Total Shareholder Return	2.11%	2.50%	1.62%	1.43%	1.01%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.